陆永奎 - the Affiliated Cancer Hospital, Guangxi Medical University

基本信息

浏览量：18

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 127 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Relationships Between Insomnia and Quality of Life in Patients with Advanced Liver Cancer: A Secondary Analysis of a Multicenter Cross-Sectional Study

Zimeng Li,Lili Song,Jiahua Leng,Ying Pang,Yi He, Zhongge Su, Yu Wang,Yuhe Zhou,Yongkui Lu,Yu Jiang, Xinkun Han,Lihua Song,Liping Wang, Xiaojun Lv, Yan Wang,Juntao Yao,Xiaohong Liu, Xiaoyi Zhou, Shuangzhi He,Yening Zhang,Jinjiang Li, Bingmei Wang,Lili Tang

Psycho-oncologyno. 5 (2025): e70157-e70157

引用0浏览0WOS引用

CACA Clinical Guideline of Holistic Psychosocial Care for Cancer Patients

Lili Tang, Shikai Wu, Xiaomei Li, Yang Cao,Xiaobing Chen,Huaidong Cheng, Ting Chi,Yi He, Jianli Hu,Qiuying Jiang,Yu Jiang,Zimeng Li, Aiguo Liu, Fang Liu,Xiaohong Liu,Yongkui Lu,Yuhan Lu, Xiaojun Lv,Xiaohong Ning,Wanmin Qiang,Wensheng Qiu,Hongjiang Song,Lihua Song, Hong Sun,Liping Wang,Pilin Wang, Xia Wang, Xiaoyi Zhou

Holistic Integrative Oncologyno. 1 (2025): 1-30

引用0浏览0引用

Eribulin Plus Carboplatin Combination for HER2-negative Metastatic Breast Cancer: a Multicenter, Real-World Cohort Study

Mengqian Ni, Lijia Zhou,Yongkui Lu, Dachuan Guo, Xiuyue Li, Lixia Li, Lidong Zhang,Meiting Chen,Lulu Zhang,Fei Xu,Zhongyu Yuan,Shusen Wang,Yanxia Shi,Anli Yang,Xin An

BMC Cancer（2024）

引用0浏览0WOS引用

Abstract PO3-05-10: Efficacy and Safety of Eribulin Plus Gemcitabine in Second-Line or Beyond for Patients with HER2-negative Metastatic Breast Cancer (MBC): A Multi-Center, Open-Label, Single-Arm, Phase II Study

PeiJian Peng, Xiao-Lu Xu,Jin-Cai Zhong,Jin-Hui Ye,Zhi-Hui Wang, Hong Wang, Hong Lin,Cai-Wen Du,Guorong Zou, Jie Ouyang, Ying-Ying Shi,Fei Xu,Geng-Sheng Yu,Yong-Kui Lu, Yong-Xia Wang,Shi-En Cui,Lu-Zhen Li

Cancer Researchno. 9_Supplement (2024): PO3-05

引用0浏览0引用

Pyrotinib and Trastuzumab Plus Palbociclib and Fulvestrant in HR+/HER2+ Breast Cancer Patients with Brain Metastasis

Dongshao Chen,Fei Xu,Yongkui Lu,Wen Xia,Caiwen Du,Dun Xiong,Dong Song,Yanxia Shi,Zhongyu Yuan,Qiufan Zheng,Kuikui Jiang,Xin An,Cong Xue,Jiajia Huang,Xiwen Bi,Meiting Chen,Jingmin Zhang,Shusen Wang,Ruoxi Hong

NPJ BREAST CANCERno. 1 (2024)

引用0浏览0WOSNATURE引用

First-line Carboplatin-Based Chemotherapy May Be Beneficial for HER2-low Advanced Breast Cancer: A Retrospective Analysis

Jingxin Li, Yijing Tang, Qianying Chen, Sen Lei,Yongkui Lu,Aihua Tan,Weimin Xie

MEDICINEno. 52 (2024)

引用0浏览0WOS引用

Efficacy and Safety of Eribulin Plus Gemcitabine in Second-Line or Beyond for Patients with HER2-negative Metastatic Breast Cancer (MBC): A Multicenter, Open-Label, Single-Arm, Phase II Study

Peijian Peng, Xiaolu Xu,Jincai Zhong,Jin-Hui Ye,Zhi-Hui Wang, Hong Wang, Hong Lin,Caiwen Du,Guorong Zou, Jie Ouyang, Ying-ying Shi,Fei Xu,Gengsheng Yu,Yongkui Lu, Yong-Xia Wang,Shi-En Cui,Lu-Zhen Li

Journal of Clinical Oncology（2024）

引用0浏览0引用

Physical Symptoms and Anxiety and Depression in Older Patients with Advanced Cancer in China: a Network Analysis

BMC GERIATRICSno. 1 (2024)

引用2浏览0WOS引用

A Phase Ib Study of PI3Kα Inhibitor Risovalisib Mesylate in Combination with Fulvestrant in Patients with PIK3CA-mutated, HR+/HER2- Advanced Breast Cancer

Journal of Clinical Oncologyno. 16_suppl (2024): 1047-1047

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn

YongKui Lu(陆永奎)

论文共 127 篇作者统计合作学者相似作者